扫描下面的二维码:

二维码

"乙肝"标签列表

[CNSLD2013]乙型肝炎母婴阻断技术与进展——Calvin Pan教授访谈2013-06-20

[APASL2013]Implications of the REVEAL-HBV Study——interview with Prof.Chien-jen Chen2013-06-18

[APASL2013]REVEAL研究的意义——陈建仁教授访谈2013-06-18

[APASL2013]IndividualizedTreatment of Chronic Hepatitis B2013-06-13

[APASL2013]慢性乙型肝炎个体化治疗2013-06-13

[CCIFLDI2013]中部肝病与感染国际高峰论坛组织委员会第二届研讨会暨肝脏疾病合并细菌感染诊断治疗新进展继教项目2013-06-13

[APASL2013]Superiority of ROADMAP strategy in HBeAg Positive CHB Patients: 2 year final result of EFFORT study2013-06-09

[APASL2013]HBeAg阳性慢性乙型肝炎患者路线图策略的优势:EFFORT研究2年最终结果2013-06-09

[APASL2013]抗HBV治疗的过去现在与未来——黎青龙院士专访2013-06-09

[APASL2013]Treatment for Chronic HBV Infection: The Long Battle——interview with Dr.Ching Lung Lai2013-06-09

[APASL2013]Peginterferon Lambda for the Treatment of HBeAg-Positive Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa2013-06-09

[APASL2013]聚乙二醇干扰素λ治疗HBeAg阳性慢性乙型肝炎:与聚乙二醇干扰素α的2B期比较研究2013-06-09

[APASL2013]HBV DNA Seroclearance Significantly Increases Rates of Spontaneous HBsAg Seroclearance in Chronic Hepatitis B Patients with Low Viral Loads2013-06-09

[APASL2013]HBV DNA血清清除显著增加低病毒载量慢性乙型肝炎患者自发性HBsAg转阴率2013-06-09

[APASL2013]A Clinical Trial on Anti-HBV-DC Vaccine Combined with Thymosin-α1 in the Inactive HBsAg Carriers2013-06-09

[APASL2013]非活动性HBsAg携带者抗HBV-DC疫苗联合胸腺肽α1治疗的临床试验2013-06-09

[APASL2013]亚太扑灭病毒肝炎联盟欢迎并全力支持全球肝炎网络成立2013-06-09

[APASL2013]A 96-week Randomized Trial of Switching to Entecavir in Chronic Hepatitis B Patients with a Complete Virologic Response to Lamivudine2013-06-08

[APASL2013]一项拉米夫定治疗获得完全病毒学应答的慢性乙型肝炎患者换用恩替卡韦的96周随机试验2013-06-08

[APASL2013]A Randomized, Three-arm Study to Optimize Lamivudine Efficacy in HBeAg Positive Chronic Hepatitis B (CHB) Patients: Week-72 EXPLORE Study Results2013-06-08

领域标签 >>



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计